Edition: India  
 
> >

Austrialian students recreate Martin Shkreli price-hike drug

euronews Friday, 2 December 2016
The man who became a global figure of greed after hiking the price of a life-saving drug by 5000 percent in the US, may have just met his match.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Guardian - < > Embed

News video: Sydney students recreate life-saving drug that had 5,000% price hike – video

Sydney students recreate life-saving drug that had 5,000% price hike – video 00:50

A group of students have managed to create a drug in their school laboratory that had its price controversially increased from US$13.50 to US$750 a tablet by former hedge fund manager Martin Shkreli. The Sydney Grammar students reproduced the drug, Daraprim, which is used to treat a rare but deadly...

You Might Like


Other recent news in Front Page

Manushi Chhillar wins MISS WORLD 2017 titleExplain Rafale cost, Rahul Gandhi tells NIRMALA SITHARAMAN
PADMAVATI row | Don't release film, think of consequences, Rajasthan Chief Minister Vasundhara Raje writes to Smriti IraniEXCLUSIVE | DEEPIKA PADUKONE on 'Padmavati': It is sad that I have to justify my actions
GUJARAT Election 2017: Hardik Patel former aide joins BJPRAHUL GANDHI elevation likely at CWC meet tomorrow
WATCH: First 'The INCREDIBLES 2' teaser shows off new superpowers of Jack Jack!Delhi University's Dyal Singh Evening College renamed as 'VANDE MATARAM MAHAVIDYALAYA'
Ecstatic ZIMBABWEANS FLOOD HARARE to celebrate expected Mugabe downfallIndia still not out of the woods: MANMOHAN SINGH on Moody's rating

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter